Schedule of Segment Reporting Information, by Segment |
Summarized financial information regarding our reportable operating segments at December 31, is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
Engine |
|
Components |
|
|
|
Distribution |
|
|
|
Power Systems |
|
Accelera |
|
Total Segments |
|
|
|
|
2024 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
8,987
|
|
|
$ |
9,894
|
|
|
|
|
$ |
11,352
|
|
|
|
|
$ |
3,500
|
|
|
$ |
369
|
|
|
$ |
34,102
|
|
|
|
|
|
Intersegment sales |
|
2,725
|
|
|
1,785
|
|
|
|
|
32
|
|
|
|
|
2,908
|
|
|
45
|
|
|
7,495
|
|
|
|
|
|
Total sales |
|
11,712
|
|
|
11,679
|
|
|
|
|
11,384
|
|
|
|
|
6,408
|
|
|
414
|
|
|
41,597
|
|
|
|
|
|
Cost of goods sold (excluding warranty expenses) |
|
8,707
|
|
|
9,346
|
|
|
|
|
9,185
|
|
|
|
|
4,506
|
|
|
643
|
|
(1) |
32,387
|
|
|
|
|
|
Warranty expenses |
|
420
|
|
|
173
|
|
|
|
|
23
|
|
|
|
|
101
|
|
|
34
|
|
|
751
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
214
|
|
|
184
|
|
|
|
|
628
|
|
|
|
|
174
|
|
|
33
|
|
(1) |
1,233
|
|
|
|
|
|
Administrative expenses |
|
582
|
|
|
555
|
|
|
|
|
382
|
|
|
|
|
421
|
|
|
70
|
|
(1) |
2,010
|
|
|
|
|
|
Research, development and engineering expenses |
|
616
|
|
|
328
|
|
|
|
|
55
|
|
|
|
|
236
|
|
|
226
|
|
(1) |
1,461
|
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
212
|
|
|
64
|
|
|
|
|
90
|
|
|
|
|
79
|
|
|
(50) |
|
(1) |
395
|
|
|
|
|
|
Other income (expense) (2)
|
|
23
|
|
|
(59) |
|
|
|
|
54
|
|
|
|
|
—
|
|
|
(183) |
|
(1) |
(165) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add back: Depreciation and amortization (3)
|
|
245
|
|
|
493
|
|
|
|
|
123
|
|
|
|
|
131
|
|
|
61
|
|
|
1,053
|
|
|
|
|
|
Segment EBITDA |
|
$ |
1,653
|
|
|
$ |
1,591
|
|
(4) |
|
|
$ |
1,378
|
|
|
|
|
$ |
1,180
|
|
|
$ |
(764) |
|
(1) |
$ |
5,038
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (5)
|
|
$ |
17
|
|
|
$ |
25
|
|
|
|
|
$ |
37
|
|
|
|
|
$ |
7
|
|
|
$ |
1
|
|
|
$ |
87
|
|
|
|
|
|
Net assets |
|
2,076
|
|
|
6,433
|
|
|
|
|
3,151
|
|
|
|
|
2,350
|
|
|
1,234
|
|
|
15,244
|
|
|
|
|
|
Investments and advances to equity investees |
|
653
|
|
|
504
|
|
|
|
|
394
|
|
|
|
|
145
|
|
|
187
|
|
|
1,883
|
|
|
|
|
|
Capital expenditures |
|
556
|
|
|
339
|
|
|
|
|
111
|
|
|
|
|
143
|
|
|
59
|
|
|
1,208
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
8,874 |
|
|
$ |
11,531 |
|
|
|
|
$ |
10,199 |
|
|
|
|
$ |
3,125 |
|
|
$ |
336 |
|
|
$ |
34,065 |
|
|
|
|
|
Intersegment sales |
|
2,810 |
|
|
1,878 |
|
|
|
|
50 |
|
|
|
|
2,548 |
|
|
18 |
|
|
7,304 |
|
|
|
|
|
Total sales |
|
11,684 |
|
|
13,409 |
|
|
|
|
10,249 |
|
|
|
|
5,673 |
|
|
354 |
|
|
41,369 |
|
|
|
|
|
Cost of goods sold (excluding warranty expenses) |
|
8,825 |
|
|
10,717 |
|
|
|
|
8,239 |
|
|
|
|
4,173 |
|
|
524 |
|
|
32,478 |
|
|
|
|
|
Warranty expenses |
|
377 |
|
|
138 |
|
|
|
|
16 |
|
|
|
|
71 |
|
|
29 |
|
|
631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
199 |
|
|
227 |
|
|
|
|
642 |
|
|
|
|
168 |
|
|
33 |
|
|
1,269 |
|
|
|
|
|
Administrative expenses |
|
587 |
|
|
634 |
|
|
|
|
354 |
|
|
|
|
399 |
|
|
57 |
|
|
2,031 |
|
|
|
|
|
Research, development and engineering expenses |
|
614 |
|
|
387 |
|
|
|
|
57 |
|
|
|
|
237 |
|
|
203 |
|
|
1,498 |
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
251 |
|
|
97 |
|
|
|
|
97 |
|
|
|
|
53 |
|
|
(15) |
|
|
483 |
|
|
|
|
|
Other income (expense) (2)
|
|
72 |
|
|
(54) |
|
|
|
|
56 |
|
|
|
|
36 |
|
|
1 |
|
|
111 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Add back: Depreciation and amortization (3)
|
|
225 |
|
|
491 |
|
|
|
|
115 |
|
|
|
|
122 |
|
|
63 |
|
|
1,016 |
|
|
|
|
|
Segment EBITDA |
|
$ |
1,630 |
|
|
$ |
1,840 |
|
(6) |
|
|
$ |
1,209 |
|
|
|
|
$ |
836 |
|
|
$ |
(443) |
|
|
$ |
5,072 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (5)
|
|
$ |
19 |
|
|
$ |
31 |
|
|
|
|
$ |
34 |
|
|
|
|
$ |
9 |
|
|
$ |
2 |
|
|
$ |
95 |
|
|
|
|
|
Net assets |
|
930 |
|
|
6,965 |
|
|
|
|
2,348 |
|
|
|
|
1,938 |
|
|
1,159 |
|
|
13,340 |
|
|
|
|
|
Investments and advances to equity investees |
|
660 |
|
|
582 |
|
|
|
|
396 |
|
|
|
|
132 |
|
|
25 |
|
|
1,795 |
|
|
|
|
|
Capital expenditures |
|
538 |
|
|
373 |
|
|
|
|
103 |
|
|
|
|
115 |
|
|
84 |
|
|
1,213 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Table continues on next page) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In millions |
|
Engine |
|
Components |
|
|
|
Distribution |
|
|
|
Power Systems |
|
Accelera |
|
Total Segments |
|
|
|
|
2022 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
External sales |
|
$ |
8,199 |
|
|
$ |
7,847 |
|
|
|
|
$ |
8,901 |
|
|
|
|
$ |
2,951 |
|
|
$ |
176 |
|
|
$ |
28,074 |
|
|
|
|
|
Intersegment sales |
|
2,746 |
|
|
1,889 |
|
|
|
|
28 |
|
|
|
|
2,082 |
|
|
22 |
|
|
6,767 |
|
|
|
|
|
Total sales |
|
10,945 |
|
|
9,736 |
|
|
|
|
8,929 |
|
|
|
|
5,033 |
|
|
198 |
|
|
34,841 |
|
|
|
|
|
Cost of goods sold (excluding warranty expenses) |
|
8,346 |
|
|
7,727 |
|
|
|
|
7,285 |
|
|
|
|
3,884 |
|
|
310 |
|
|
27,552 |
|
|
|
|
|
Warranty expenses |
|
329 |
|
|
64 |
|
|
|
|
6 |
|
|
|
|
70 |
|
|
20 |
|
|
489 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling expenses |
|
165 |
|
|
158 |
|
|
|
|
550 |
|
|
|
|
147 |
|
|
18 |
|
|
1,038 |
|
|
|
|
|
Administrative expenses |
|
462 |
|
|
513 |
|
|
|
|
304 |
|
|
|
|
269 |
|
|
47 |
|
|
1,595 |
|
|
|
|
|
Research, development and engineering expenses |
|
506 |
|
|
309 |
|
|
|
|
52 |
|
|
|
|
240 |
|
|
171 |
|
|
1,278 |
|
|
|
|
|
Equity, royalty and interest income (loss) from investees |
|
160 |
|
(7) |
71 |
|
|
|
|
77 |
|
|
|
|
43 |
|
|
(2) |
|
|
349 |
|
|
|
|
|
Other income (expense) (2)
|
|
33 |
|
|
6 |
|
|
|
|
(35) |
|
|
|
|
10 |
|
|
(2) |
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Russian suspension costs (8)
|
|
33 |
|
(9) |
5 |
|
|
|
|
54 |
|
|
|
|
19 |
|
|
— |
|
|
111 |
|
|
|
|
|
Add back: Depreciation and amortization (3)
|
|
205 |
|
|
304 |
|
|
|
|
114 |
|
|
|
|
120 |
|
|
38 |
|
|
781 |
|
|
|
|
|
Segment EBITDA |
|
$ |
1,535 |
|
|
$ |
1,346 |
|
(10) |
|
|
$ |
888 |
|
|
|
|
$ |
596 |
|
|
$ |
(334) |
|
|
$ |
4,031 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income (5)
|
|
$ |
14 |
|
|
$ |
12 |
|
|
|
|
$ |
16 |
|
|
|
|
$ |
7 |
|
|
$ |
— |
|
|
$ |
49 |
|
|
|
|
|
Net assets |
|
1,451 |
|
|
7,306 |
|
|
|
|
2,698 |
|
|
|
|
2,382 |
|
|
1,158 |
|
|
14,995 |
|
|
|
|
|
Investments and advances to equity investees |
|
617 |
|
|
617 |
|
|
|
|
352 |
|
|
|
|
138 |
|
|
33 |
|
|
1,757 |
|
|
|
|
|
Capital expenditures |
|
368 |
|
|
264 |
|
|
|
|
114 |
|
|
|
|
96 |
|
|
74 |
|
|
916 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Included $112 million of charges in cost of sales, $10 million of charges in selling, general and administrative expenses, $2 million of charges in research and development expenses, $17 million of charges in equity, royalty and interest income (loss) from investees, $171 million of charges in other operating expenses and $312 million of charges in EBITDA, all related to Accelera strategic reorganization actions in the fourth quarter of 2024. See NOTE 22, "ACCELERA STRATEGIC REORGANIZATION ACTIONS," for additional information.
|
|
|
|
|
(2) Other income (expense) includes other operating expense, net and other income, net from our Consolidated Statements of Net Income.
|
(3) Depreciation and amortization are not considered significant segment expenses but are presented here to reconcile to EBITDA, the measure used by our CODM. Depreciation and amortization, as shown on a segment basis, excludes the amortization of debt discount and deferred costs included in our Consolidated Statements of Net Income as interest expense. The amortization of debt discount and deferred costs were $12 million, $8 million and $3 million for the years ended 2024, 2023 and 2022, respectively. A portion of depreciation expense is included in research, development and engineering expense.
|
(4) Included $21 million of costs associated with the divestiture of Atmus for the year ended December 31, 2024.
|
|
|
|
|
(5) Interest income is a component of other income (expense).
|
|
|
|
|
(6) Included $78 million of costs associated with the divestiture of Atmus for the year ended December 31, 2023.
|
|
|
|
|
(7) Included a $28 million impairment of our joint venture with KAMAZ and $3 million of royalty charges as part of our costs associated with the indefinite suspension of our Russian operations. See NOTE 24, "RUSSIAN OPERATIONS," for additional information.
|
|
|
|
|
(8) See NOTE 24, "RUSSIAN OPERATIONS," for additional information.
|
|
|
|
|
(9) Included $31 million of Russian suspension costs reflected in the equity, royalty and interest income (loss) from investees line above.
|
|
|
|
|
(10) Included $83 million of costs related to the acquisition and integration of Meritor and $28 million of costs associated with the divestiture of Atmus.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of segment information |
A reconciliation of our segment information to the corresponding amounts in our Consolidated Statements of Net Income is shown in the table below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31, |
In millions |
|
2024 |
|
2023 |
|
2022 |
TOTAL SEGMENT EBITDA |
|
$ |
5,038
|
|
|
$ |
5,072 |
|
|
$ |
4,031 |
|
Intersegment eliminations and other (1)
|
|
1,288
|
|
|
(2,055) |
|
|
(232) |
|
|
|
|
|
|
|
|
Less: |
|
|
|
|
|
|
Interest expense |
|
370
|
|
|
375 |
|
|
199 |
|
Depreciation and amortization |
|
1,053
|
|
|
1,016 |
|
|
781 |
|
INCOME BEFORE INCOME TAXES |
|
$ |
4,903
|
|
|
$ |
1,626 |
|
|
$ |
2,819 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) Intersegment eliminations and other included a $1.3 billion gain related to the divestiture of Atmus and $14 million of costs associated with the divestiture of Atmus for the year ended December 31, 2024. The year ended December 31, 2023, included $2.0 billion related to the Settlement Agreements charge, $22 million of costs associated with the divestiture of Atmus and $21 million of voluntary retirement and voluntary separation charges. The year ended December 31, 2022, included $53 million of costs associated with the divestiture of Atmus. See NOTE 14, "COMMITMENTS AND CONTINGENCIES," and NOTE 21, "ATMUS INITIAL PUBLIC OFFERING (IPO) AND DIVESTITURE," for additional information.
|
|
|
|
|
|
|
|
|